Selenium supplementation and insulin resistance in a randomized, clinical trial
Author
Jacobs, Elizabeth TheresaLance, Peter
Mandarino, Lawrence J
Ellis, Nathan A
Chow, H-H Sherry
Foote, Janet
Martinez, Jessica A
Hsu, Chiu-Hsieh Paul
Batai, Ken
Saboda, Kathylynn
Thompson, Patricia A
Affiliation
Univ Arizona, Dept Epidemiol & BiostatUniv Arizona, Canc Ctr
Univ Arizona, Dept Nutr Sci
Univ Arizona, Dept Med
Univ Arizona, Ctr Dispar Diabet Obes & Metab
Univ Arizona, Dept Surg
Issue Date
2019-06
Metadata
Show full item recordPublisher
BMJ PUBLISHING GROUPCitation
Jacobs, E. T., Lance, P., Mandarino, L. J., Ellis, N. A., Chow, H. S., Foote, J., ... & Thompson, P. A. (2019). Selenium supplementation and insulin resistance in a randomized, clinical trial. BMJ Open Diabetes Research and Care, 7(1), e000613.Rights
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Objective: While controversial, observational and randomized clinical trial data implicate the micronutrient selenium (Se) in the development of type 2 diabetes (T2D). The aim of this study was to test the hypothesis that Se supplementation adversely affects pancreatic beta-cell function and insulin sensitivity. Research design and methods: In a subset of 400 individuals participating in a randomized, placebocontrolled trial of Se at 200 mu g/day for colorectal adenomatous polyps, fasting plasma glucose and insulin were measured before randomization and within 6 months of completing intervention. Change in the homeostasis model assessment-beta cell function (HOMA2-%beta) and insulin sensitivity (HOMA2-%S) were compared between arms. A subgroup of 175 (79 Se and 96 placebo) participants underwent a modified oral glucose tolerance test (mOGTT) at the end of intervention and change in glucose values was assessed. Results: No statistically significant differences were observed for changes in HOMA2-%beta or HOMA2-%S between those who received Se compared with placebo. After a mean of 2.9 years on study, mean HOMA2-%beta values were 3.1 +/- 24.0 and 3.1 +/- 29.8 for the Se and placebo groups, respectively (p=0.99). For HOMA2-%S, the values were -0.5 +/- 223.2 and 80.9 +/- 1530.9 for the Se and placebo groups, respectively (p=1.00). Stratification by sex or age did not reveal any statistically significant effects on insulin sensitivity by treatment group. For mOGTT, mean baseline fasting blood glucose concentrations were significantly higher among participants in the placebo group compared with the Se group (96.6 +/- 14.6 and 92.3 +/- 12.0, respectively; p=0.04), a trend which remained through the 20 min assessment. Conclusions: These findings do not support a significant adverse effect of daily Se supplementation with 200 mu g/day of selenized yeast on beta-cell function or insulin sensitivity as an explanation for previously reported associations between Se and T2D. Further clarification of longer term effects of Se is needed.Note
Open access journalISSN
2052-4897PubMed ID
30899530Version
Final published versionSponsors
National Cancer Institute Cancer Center Support Grant [P30 CA023074]; NIH/NCI [R01CA151708, P01 CA041108]; NIH [R01DK047396]ae974a485f413a2113503eed53cd6c53
10.1136/bmjdrc-2018-000613
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC.
Related articles
- Effects of selenium supplementation on glucose homeostasis, inflammation, and oxidative stress in gestational diabetes: Randomized, double-blind, placebo-controlled trial.
- Authors: Asemi Z, Jamilian M, Mesdaghinia E, Esmaillzadeh A
- Issue date: 2015 Oct
- A randomized, placebo-controlled trial of selenium supplementation in patients with type 2 diabetes: effects on glucose homeostasis, oxidative stress, and lipid profile.
- Authors: Faghihi T, Radfar M, Barmal M, Amini P, Qorbani M, Abdollahi M, Larijani B
- Issue date: 2014 Nov-Dec
- Selenium Supplementation Affects Insulin Resistance and Serum hs-CRP in Patients with Type 2 Diabetes and Coronary Heart Disease.
- Authors: Farrokhian A, Bahmani F, Taghizadeh M, Mirhashemi SM, Aarabi MH, Raygan F, Aghadavod E, Asemi Z
- Issue date: 2016 Apr
- Cut-off points of homeostasis model assessment of insulin resistance, beta-cell function, and fasting serum insulin to identify future type 2 diabetes: Tehran Lipid and Glucose Study.
- Authors: Ghasemi A, Tohidi M, Derakhshan A, Hasheminia M, Azizi F, Hadaegh F
- Issue date: 2015 Oct
- Zinc supplementation in prediabetes: A randomized double-blind placebo-controlled clinical trial.
- Authors: Ranasinghe P, Wathurapatha WS, Galappatthy P, Katulanda P, Jayawardena R, Constantine GR
- Issue date: 2018 May

